Are next-generation sequencing results knocking on Heaven’s door for transplantation planning in chronic myelomonocytic leukemia?
- 1 March 2020
- journal article
- editorial
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (3), 530-533
- https://doi.org/10.3324/haematol.2019.240853
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimentalBlood Cancer Journal, 2018
- Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasmsOncotarget, 2018
- DNMT3A mutations are associated with inferior overall and leukemia‐free survival in chronic myelomonocytic leukemiaAmerican Journal of Hematology, 2016
- Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemiaBlood, 2016
- ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patientsLeukemia, 2014
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic LeukemiaJournal of Clinical Oncology, 2013
- Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemiaBlood, 2013
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- Cytogenetic risk stratification in chronic myelomonocytic leukemiaHaematologica, 2010
- Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patientsBlood, 2002